Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty Drugsallcareadvantage Physician‑Administered Drugs Prio…
    Ask Trek AI about this page
    CurrentallcareadvantagePolicy 001.1

    Physician-Administered Drugs Prior Authorization

    Customize your policy alerts

    Sign up for allcareadvantage Policy 001.1 alerts

    Get alerted when Policy 001.1 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines prior authorization criteria and process for coverage of physician- or clinician-administered drugs and biologics for AllCare Advantage members; applies to drugs given by a healthcare professional in outpatient clinical settings.

    Policy Summary
    Payerallcareadvantage
    PolicyPhysician-Administered Drugs Prior Authorization
    Policy CodePolicy 001.1
    Change TypeRoutine review — no material changes
    Effective DateJun 1, 2026
    Last ReviewJun 1, 2026
    Next Review DateJun 1, 2026
    Key ActionSubmit prior authorization with a valid drug code, documentation of medical rationale if using a non-preferred agent, and attach applicable guidelines or efficacy documentation at renewal.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    8decision steps in approval algorithm
    up to 12 monthsapproval duration upon renewal
    clinical/adminpolicy classification

    Coverage Criteria

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Initial prior authorization decision algorithm

    Covered when the sequential approval criteria are satisfied according to the algorithm below

    Sequential criteria: 1) Request must include a valid drug code; if not, do not approve. 2) If an applicable CCO drug policy addresses the requested agent, refer to that specific policy; if not, continue. 3) If a preferred lower-cost alternative exists, redirect to the preferred agent; if provider asserts the preferred agent cannot be used, medical rationale must be submitted; absence of required rationale = deny. 4) If an applicable OHP guideline exists for the agent, attach the guideline and evaluate against it. 5) If no OHP guideline applies, check for an applicable MCG guideline and attach if applicable. 6) If guideline(s) apply, approve only if the request meets the applicable guideline(s); otherwise deny. 7) If no guideline applies, determine whether use is reasonable and necessary considering FDA‑approved indication; approve if reasonable. 8) If not reasonable by FDA indication, evaluate off‑label use for medical acceptance and safety per major compendia; approve if accepted, otherwise deny.

    Flow proceeds stepwise; approvals occur at decision points when criteria are met (see policy algorithm).

    Renewal criteria

    Renewal evaluation

    Renewal requests are denied if the member did not meet the initial criteria. For renewal approval, documentation must demonstrate treatment efficacy; if efficacy documentation is provided, approve for a medically appropriate period, up to 12 months.up to 12 months

    Efficacy documentation required for renewal.

    The policy applies to physician‑administered drugs and biologics (non‑vaccine) given by a medical professional in an outpatient clinical setting and requires that use be reasonable and medically necessary according to accepted standards of medical practice. Medications administered for purposes other than treatment of a specific condition, illness, or injury are not covered. Likewise, parenteral (injection) administration is not covered when standard medical practice indicates that an effective and accepted oral alternative exists. Treatments that exceed accepted frequency or duration for injections are also excluded.

    Use is considered not medically necessary when injections are provided for non‑treatment purposes (for example, when the drug is not intended to treat a diagnosed condition), when an oral route is effective and is the accepted or preferred method of administration, or when the proposed frequency or duration of injectable therapy exceeds accepted standards of practice. Requests that meet any of these conditions should be denied as not medically necessary.

    Initial Therapy Criteria

    Initial therapy

    Initial authorization expectations

    Initial therapy: Initial approval requires a valid drug code, assessment against any applicable CCO/OHP/MCG guideline, submission of medical rationale if requesting a non‑preferred agent, and determination that the use is reasonable and necessary considering FDA indication or accepted off‑label compendia evidence.

    Follow the stepwise algorithm in policy (see Initial prior authorization decision algorithm).

    Continuation / Renewal Criteria

    Renewal / continuation

    Criteria for continued coverage

    Continuation: At renewal, the member must have met the initial authorization criteria and there must be documentation supporting treatment efficacy; if both are present, approve for a medically appropriate period up to 12 months. If the initial criteria were not met, deny renewal.up to 12 months

    Continuation contingent on documentation of efficacy and prior criteria being met.

    Provider Actions & Prior Authorization Process

    Prior Authorization

    Prior authorization must follow the stepwise review algorithm

    Prior authorization is required and follows a stepwise review: confirm the request includes a valid drug code; determine whether an applicable CCO drug policy applies (refer to that policy if present); assess for a preferred lower-cost alternative and require medical rationale if bypassing it; attach applicable OHP or MCG guideline when available and evaluate the request against those guidelines; if no guideline applies, determine whether use is reasonable and necessary considering FDA indication; if not, evaluate off‑label use against major compendia for medical acceptance and safety.

    • Step 1: Valid drug code required; requests with invalid codes are not approved.
    • Step 2: If a CCO drug policy exists for the agent, refer to that policy.
    • Steps 3–4: Redirect to preferred lower-cost agent when available; require medical rationale to bypass.
    • Steps 5–7: Attach and follow applicable OHP or MCG guidelines when present.
    • Steps 8–9: If no guideline applies, evaluate FDA indication or off-label use per major compendia.
    Step Therapy

    Redirect to preferred lower-cost agent unless medical rationale provided

    When a preferred lower-cost alternative exists, the request should be redirected to that preferred agent unless the provider submits a medical rationale explaining why the preferred agent cannot be used.

    • If provider does not provide medical rationale to bypass the preferred agent, the PA is denied per the decision algorithm.
    Documentation Required

    Required documentation for PA and renewals

    Providers must submit the valid drug code for the requested agent and attach applicable guideline documents; if requesting a non‑preferred agent, include medical rationale explaining why the preferred agent cannot be used. For renewals, submit documentation demonstrating treatment efficacy.

    • Include valid drug code on the PA request.
    • Attach applicable OHP or MCG guideline when available.
    • Provide clinical rationale when bypassing a preferred agent.
    • For renewals, provide documentation of treatment efficacy to qualify for approval up to 12 months.
    Denial Risk

    Denial triggers when algorithm requirements are unmet

    Denials occur when required elements of the algorithm are not met: do not approve requests with an invalid drug code, and deny PA when a preferred lower‑cost alternative exists but the provider fails to submit medical rationale to justify use of a non‑preferred agent; deny when the request does not meet applicable guidelines or accepted off‑label compendia.

    • Invalid drug code → do not approve.
    • No medical rationale to bypass preferred agent → deny PA.
    • Request fails to meet applicable OHP/MCG guideline or accepted off‑label compendia → deny PA.

    Step Therapy / Preferred Agent Redirection

    StepQuestion / actionResulting action
    {"text":"1","status":""}|{"text":"Is the request for a valid drug code?","status":""}|{"text":"If yes, proceed to step 2; if no, do not approve — clarify requested agent.","status":"not_covered"}
    {"text":"2","status":""}|{"text":"Is there an applicable CCO drug policy that addresses the requested agent?","status":""}|{"text":"If yes, refer to that specific drug policy for coverage criteria; if no, proceed to step 3.","status":""}
    {"text":"3","status":""}|{"text":"Is there a preferred lower-cost alternative that could be used in place of the requested agent?","status":""}|{"text":"If yes, redirect to the preferred agent and proceed to step 4; if no, proceed to step 5.","status":""}
    {"text":"4","status":""}|{"text":"Did the provider submit medical rationale supporting that the member cannot use the preferred agent?","status":""}|{"text":"If yes, proceed to step 5; if no, deny prior authorization.","status":"not_covered"}
    {"text":"5","status":""}|{"text":"Is there an applicable OHP guideline that addresses the requested agent?","status":""}|{"text":"If yes, attach the guideline and proceed to step 7; if no, proceed to step 6.","status":""}
    {"text":"6","status":""}|{"text":"Is there an applicable MCG guideline that addresses the requested agent?","status":""}|{"text":"If yes, attach the guideline and proceed to step 7; if no, proceed to step 8.","status":""}
    {"text":"7","status":""}|{"text":"Does the request meet the applicable guideline(s) for coverage of the requested agent?","status":""}|{"text":"If yes, approve; if no, deny prior authorization.","status":""}
    {"text":"8","status":""}|{"text":"Is use of the agent reasonable and necessary for the individual patient considering FDA‑approved indication?","status":""}|{"text":"If yes, approve; if no, evaluate off‑label use for medical acceptance per major compendia and safety — approve if accepted, otherwise deny prior authorization.","status":""}

    Site of Care

    Note

    Office‑administered drugs: applicable site of care

    This policy applies to physician‑administered drugs and biologics that are typically given by a medical professional in a physician's office or other outpatient clinical setting (excluding vaccines).

    • Site of care: administration in office or outpatient clinical setting by a healthcare professional.

    Definitions

    Physician‑administered drugs / biologics — definition
    DefinitionMedications (excluding vaccines) that are administered by a physician or other healthcare professional in a physician's office or other outpatient clinical setting.
    Clinical requirementUse must be reasonable and medically necessary for diagnosis or effective treatment of a specific illness or injury based on accepted standards of medical practice.
    Route and settingTypically given parenterally or by other clinician-administered routes in office/outpatient settings rather than self-administered at home.
    When injections are not coveredParenteral administration is not covered if standard medical practice indicates an equally effective oral route is accepted or preferred.
    Non-treatment uses excludedMedications given for purposes other than treatment of a particular condition, illness, or injury are not covered.
    Frequency/duration limitsMedications exceeding the frequency or duration of injections indicated by accepted standards of medical practice are not covered.

    Background

    Physician‑administered drugs and biologics are medications (excluding vaccines) typically given by a healthcare professional in a physician’s office or other outpatient setting. Coverage requires that the medication be reasonable and medically necessary for diagnosis or effective treatment of a specific illness or injury per accepted standards of medical practice. The policy emphasizes that therapeutic injections should be reserved for situations where equally effective oral medications cannot be used without significant or increased side effects.

    Policy Summary
    Payerallcareadvantage
    PolicyPhysician-Administered Drugs Prior Authorization
    Policy CodePolicy 001.1
    Change TypeRoutine review — no material changes
    Effective DateJun 1, 2026
    Last ReviewJun 1, 2026
    Next Review DateJun 1, 2026
    Key ActionSubmit prior authorization with a valid drug code, documentation of medical rationale if using a non-preferred agent, and attach applicable guidelines or efficacy documentation at renewal.
    SourceLink
    On This Page
    Coverage CriteriaInitial Therapy CriteriaContinuation / Renewal CriteriaProvider Actions & Prior Authorization ProcessStep Therapy / Preferred Agent RedirectionSite of CareDefinitionsBackground